Verista, a leading transformative compliance and automation solutions organization for the life sciences industry, recently acquired Hawkins Point, a leader in life sciences business and technology services. The acquisition expands and improves Verista’s scope of services and capabilities, adding research and development (R&D) and commercialization technology capabilities for large pharma, early-stage biotech and medical device companies, while broadening its geographic footprint to better support its clients’ growing needs.
The addition of Hawkins Point, based in Massachusetts, leverages Verista’s pedigree in FDA-regulated services in information technology and manufacturing technology. It completes Verista’s lifecycle support for life sciences companies, which now includes consulting, technology, and manufacturing services – from early-stage research through commercialization and beyond.
“The Hawkins Point team shares Verista’s mission of trust and ultimately improving the quality of life for patients,” says Heather Morris Kyer, the co-founder of Hawkins Point, who will join the Verista leadership team. “We are thrilled to be an important part of Verista, as we collectively gain greater scale and increased capabilities to serve our clients.”
“Adding the Hawkins Point team’s deep expertise in R&D and commercialization services is a natural extension of Verista’s capabilities in compliance, automation and validation solutions,” says Manny Soman, CEO, Verista. “Together, we will expand Verista’s geographic reach into New England with synergized services for the highly regulated life sciences arena.”
The Hawkins Point acquisition was led by private equity sponsor Lightview Capital, which originally invested in Clarke in 2015, and Maranon Capital, which provided debt financing. Covex LLC was added to the portfolio in 2020. Hawkins Point was advised in the transaction by Carl Marks Securities, LLC, and Goodwin Procter LLP.
Verista is a leading business and technology consultancy firm that provides systems, compliance, validation and quality solutions to life science companies enabling them to improve health and improve lives. We help clients solve their most critical and complex challenges across the GxP lifecycle, from preclinical and clinical to commercialization, manufacturing and distribution – bringing together decades of knowledge, the most advanced engagement platforms and transformative technologies. This allows clients to benefit from the ease, efficiency and trust that results from working with one partner who excels across specialties. Verista’s clients trust the company’s 500+ experts to deliver consistent, safe, and high-quality results across the product development lifecycle. For more information, visit www.verista.com.
About Hawkins Point
Hawkins Point, located in Westford, MA, is a business and technology services firm focused on serving organizations and the people in life sciences. Founded in 2013, with deep domain expertise in every stage of the drug development lifecycle and patient journey, Hawkins Point has been nationally recognized for its success and growth. Ranked number 388 on Inc. 500’s list of America’s fastest-growing private companies, the company has received numerous industry awards including being named number 6 on Boston Business Journal’s list of fastest growing companies in Massachusetts. In 2018, the company was named one of the 50 Fastest Growing Women-Owned/Led Companies in the country as chosen by the Women Presidents’ Organization (WPO). For more information, visit hawkinspointpartners.com.
About Lightview CapitalTM
Lightview Capital is a leading private equity firm focused on providing its portfolio companies deep industry knowledge, insightful experience, and active resources to unlock growth and drive value. Lightview Capital’s approachable investment style combines deep operational and financial experience with an entrepreneurial spirit that delivers measurable results. For more information, visit lightviewcapital.com.